Related Experiment Video
Updated: Nov 6, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Stopping the Clock on Seizures!
Xiaoqin Fu1, Judy S Liu2, Peijun Li1
1The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
Abstract:
A recent paper by Zhang et al. shows that REV-ERBα, a negative regulator of the circadian molecular clock, is pro-convulsant through its action on GABA signaling. The findings support the role of the circadian molecular clock in epilepsy and suggest REV-ERBα as a potential therapeutic target for the management of seizures.
Insights
REV-ERBα, a regulator of the circadian clock, promotes seizures by affecting GABA signaling. This suggests targeting REV-ERBα could be a new epilepsy treatment strategy.
Area of Science:
- Neuroscience
- Chronobiology
- Epilepsy Research
Background:
- The circadian molecular clock regulates numerous physiological processes.
- Disruptions in circadian rhythms are implicated in various neurological disorders, including epilepsy.
- The specific role of circadian regulators in seizure susceptibility remains incompletely understood.
Purpose of the Study:
- To investigate the role of REV-ERBα, a core component of the circadian clock, in seizure activity.
- To determine the molecular mechanisms by which REV-ERBα influences neuronal excitability and GABAergic signaling.
- To evaluate REV-ERBα as a potential therapeutic target for epilepsy.
Main Methods:
- Utilized molecular biology techniques to assess REV-ERBα expression and function.
- Employed electrophysiological methods to study GABA signaling in the presence of altered REV-ERBα activity.
- Investigated the effects of modulating REV-ERBα on seizure thresholds in relevant models.
Main Results:
- Zhang et al. demonstrated that REV-ERBα acts as a pro-convulsant factor.
- REV-ERBα was shown to negatively impact GABA signaling, a key inhibitory neurotransmitter system.
- Modulation of REV-ERBα activity directly influenced seizure susceptibility.
Conclusions:
- REV-ERBα plays a significant role in regulating seizure threshold.
- The findings highlight the involvement of the circadian molecular clock in the pathophysiology of epilepsy.
- REV-ERBα emerges as a promising therapeutic target for developing novel anti-seizure medications.
More Related Videos
10:25Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
Published on: March 27, 2021
08:43Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
Published on: July 21, 2015
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Glutamate Antagonists